OMEROS CORP Loans Payable, Noncurrent
OMEROS CORP (OMER) had Loans Payable, Noncurrent of $0 as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation › Notes and Loans, Noncurrent
us-gaap:LongTermLoansPayable · last filed 2026-03-31
- 2025-12-31: Loans Payable, Noncurrent $0.00.
- 2025-09-30: Loans Payable, Noncurrent $87.48M.
- 2025-06-30: Loans Payable, Noncurrent $87.31M.
- 2025-03-31: Loans Payable, Noncurrent $88.56M.
| Period end | Loans Payable, Noncurrent | Loans Payable, Noncurrent as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-31 | |
| 2025-09-30 | $87.48M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $87.31M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $88.56M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $69.64M 10-K · filed 2026-03-31 | $69.41M 10-K · filed 2025-03-31 |
| 2024-09-30 | $92.43M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $94.51M 10-Q · filed 2024-08-07 | |
| 2023-12-31 | $0.00 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |